SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-219185
Filing Date
2022-08-12
Accepted
2022-08-12 06:10:59
Documents
12
Period of Report
2022-08-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d341730d8k.htm   iXBRL 8-K 23441
  Complete submission text file 0001193125-22-219185.txt   146984

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zyme-20220811.xsd EX-101.SCH 2528
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20220811_lab.xml EX-101.LAB 18798
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20220811_pre.xml EX-101.PRE 11774
6 EXTRACTED XBRL INSTANCE DOCUMENT d341730d8k_htm.xml XML 3559
Mailing Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4
Business Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 221157696
SIC: 2834 Pharmaceutical Preparations